Related Experiment Video
Updated: Jul 20, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus
A Tincani1, C B Rebaioli, M Taglietti
1Reumatologia e Immunologia Clinica, Ospedale Civile, Piazza Spedali Civili 1, 25125 Brescia, Italy. tincani@bresciareumatologia.it
Insights
Systemic autoimmune diseases can cause serious cardiac complications. Autoantibodies contribute to inflammation, thrombosis, and conduction defects, impacting heart structures and patient outcomes.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Cardiac involvement is a major cause of morbidity and mortality in systemic autoimmune diseases.
- Multiple heart structures can be affected through various pathogenic mechanisms.
Purpose of the Study:
- To summarize the cardiac complications associated with systemic autoimmune diseases.
- To highlight the role of autoantibodies in cardiac pathology.
Main Methods:
- Review of literature on cardiac manifestations in systemic autoimmune diseases.
- Analysis of pathogenic mechanisms involving autoantibodies.
Main Results:
- Non-organ-specific autoantibodies trigger inflammation (Libman-Sacks endocarditis, myocarditis, pericarditis).
- Anti-phospholipid antibodies are linked to coronary thrombosis and vasculopathy.
- Anti-SSA/Ro and anti-SSB/La antibodies cause conduction abnormalities and endocardial fibroelastosis.
Conclusions:
- Autoantibodies play a critical role in the diverse cardiac manifestations of systemic autoimmune diseases.
- Understanding these mechanisms is crucial for managing cardiovascular risks in affected patients.
Abstract:
Cardiac involvement is one of the main complications substantially contributing to the morbidity and mortality of patients suffering from systemic autoimmune diseases. All the anatomical heart structures can be affected, and multiple pathogenic mechanisms have been reported. Non-organ-specific autoantibodies have been implicated in immune complex formation and deposition as the initial triggers for inflammatory processes responsible for Libman-Sacks verrucous endocarditis, myocarditis and pericarditis. Anti-phospholipid antibodies have been associated with thrombotic events in coronary arteries, heart valve involvement and intra-myocardial vasculopathy in the context of primary and secondary anti-phospholipid syndrome. Antibodies-SSA/Ro and anti-SSB/La antigens play a major pathogenic role in affecting the heart conduction tissue leading to the electrocardiographic abnormalities of the neonatal lupus syndrome and have been closely associated with endocardial fibroelastosis.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease IV: Nursing Management
Rh Blood Group